Related Experiment Video
Updated: Oct 13, 2025

Antimicrobial Peptides Produced by Selective Pressure Incorporation of Non-canonical Amino Acids
Published on: May 4, 2018
Lipopeptide Pepducins as Therapeutic Agents
Emily Michael1, Lidija Covic1, Athan Kuliopulos2
1Center of Hemostasis and Thrombosis Research, Division of Hematology-Oncology, Department of Medicine, Tufts Medical Center, Tufts University School of Medicine, Boston, MA, USA.
Pepducins, lipidated peptides targeting G protein-coupled receptors (GPCRs), offer versatile therapeutic potential. An advanced compound, PZ-128, demonstrated safety and efficacy in phase 2 cardiac trials for myonecrosis and thrombosis.
Area of Science:
- Biochemistry
- Pharmacology
- Molecular Biology
Background:
- G protein-coupled receptors (GPCRs) are crucial cell surface receptors involved in numerous physiological processes.
- Modulating GPCR signaling is a key strategy for developing novel therapeutics.
- Pepducins are a class of lipidated peptides designed to interact with intracellular GPCR loops.
Purpose of the Study:
- To introduce pepducins as a versatile class of compounds for modulating GPCR signaling.
- To highlight the therapeutic potential of pepducins in treating various diseases.
- To present the development and clinical progress of an advanced pepducin compound, PZ-128.
Main Methods:
- Design and synthesis of various pepducins.
- Characterization of pepducin activity on GPCRs (agonism, antagonism, biased signaling).
- Preclinical and clinical evaluation of lead compounds, including PZ-128.
Main Results:
- Pepducins demonstrate a wide range of modulatory activities on GPCRs.
- PZ-128 has successfully completed phase 2 clinical trials in cardiac patients.
- PZ-128 showed demonstrated safety and efficacy in suppressing myonecrosis and arterial thrombosis.
Conclusions:
- Pepducins represent a promising therapeutic modality targeting GPCRs.
- PZ-128 showcases the clinical viability of pepducins for cardiovascular conditions.
- Further development of pepducins could lead to novel treatments for diverse human diseases.
More Related Videos
12:02An Efficient Method for the Synthesis of Peptoids with Mixed Lysine-type/Arginine-type Monomers and Evaluation of Their Anti-leishmanial Activity
Published on: November 2, 2016
08:48Development of a Backbone Cyclic Peptide Library as Potential Antiparasitic Therapeutics Using Microwave Irradiation
Published on: January 26, 2016
Related Concept Videos
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Biological Methods for Microbial Control
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Gene Regulation in Microbial Communities: Quorum Sensing
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include: